Bain backs Newton biotech in $155M fundraise


In a tough funding market for young biotechs, a Newton company just raised a $155 million round led by Bain Capital Life Sciences and Redmile Group.

Previous Tecum Capital invests $10M in Johnstown-based Gautier Steel
Next $13 billion Dayton company secures approval for joint venture in Michigan